Searched for
SANOFI AVENTIS
Glenmark gets tentative FDA nod for Sanofi's generic MultaqHowever, the company cannot sell the product in the US as it is involved in a patent litigation with Sanofi in the district court of Delawa...- Cipla losses appeal in US court for animal healthcare productDrug firm Cipla today said it has lost an appeal in a US court over a patent case against Merial Ltd regarding an animal healthcare product.
- Aventis Pharma renamed as Sanofi IndiaThe shareholders of the company had earlier approved the name change at the annual general meeting held on May 3, a company statement said.
- Sanofi-Aventis in advanced talks to buy majority stake in Universal Medicare to scale up OTC biz in IndiaAccording to a person close to the deal, Sanofi-Aventis may buy a majority stake or key brands valuing the Indian company at around Rs 450 ...
- Sanofi Aventis plans to buy Generics, OTC brandsIt was also believed to been in the fray to buy Actis' 63% stake in Paras Pharmaceuticals, that was eventually acquired by Reckitt Benckise...
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.
- Sanofi extends $18.5bn offer for Genzyme till Jan 21Sanofi-aventis has a significant presence in India. Last year, Sanofi-aventis had sought to acquire an 80pc stake in ShanthaBiotechnics for...
- Sanofi extends bid for GenzymeFrench pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving the off...
- Sanofi-Aventis likely to buy Genzyme for USD 19 bn: ReportFrench drug maker Sanofi-Aventis is likely to make an formal offer to acquire US-based biotech company Genzyme for USD 19 billion, says a m...
- Merck plans to shift India head office to MumbaiUS-based drugmaker Merck plans to relocate headquarter of its India office to Mumbai, making it the third major pharma company to shift key...
- Sanofi-Aventis to buy Chattem for $1.9 bnFrench drug maker Sanofi-Aventis SA to buy US health care company Chattem Inc for about $1.9 billion in cash.
- Sanofi-Aventis scans India for acquisitionsSanofi-Aventis which bought companies in Brazil, Mexico, and the home-grown Shanta Biotech this year, has sent a delegation to India to fin...
- Sanofi Aventis-Piramal deal falls through over valuationFrench pharmaceutical giant Sanofi Aventis’ proposed deal to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through...
- Sanofi Aventis's Piramal plans fall throughFrench pharma major Sanofi Aventis's plans to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through due to differe...
- Piramal Health up 13% on Sanofi stake buyThe news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...
- Sanofi seen ahead in Piramal raceSanofi-Aventis has completed due diligence and the deal could be closed soon, one of the two persons told ET on condition of anonymity.
- Zentiva recommends shareholders reject Sanofi Aventis' bidThe board of Czech generic drugs maker Zentiva N.V. said it has recommended that its shareholders reject a takeover offer from French pharm...
- US firm files suit against Dabur PharmaUS-based Sanofi-Aventis LLC has filed a lawsuit against Dabur Pharma and its UK arm - Dabur Oncology Pte, over a USFDA filing seeking appro...
- Plavix copies hit Sanofi-Aventis, net drops 12%Sanofi-aventis reported a 12% drop in third-quarter profit on Tuesday, citing the loss of top-selling blood thinner Plavix to generic compe...
- Sanofi-Aventis revises open offer for Aventis PharmaThe schedule of Sanofi-Aventis' open offer for shareholders of Aventis Pharma Ltd has been revised by DSP Merrill Lynch, manager of the off...
Load More- Sanofi-Aventis in advanced talks to buy majority stake in Universal Medicare to scale up OTC biz in India
